Company Search:
Advanced Search
Sponsored Links
Syngene International Ltd Company Snapshot
Syngene International Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Syngene International Ltd with three other miscellaneous service companies in Asia: Takara Bio Inc of JAPAN (2020 sales of 34.57 billion Japanese Yen [US$327.33 million] of which 93% was Bio support), Take Solutions Pvt Limited (22.13 billion Indian Rupees [US$295.86 million] ), and Shin Nippon Biomedical Laboratories Ltd which is based in JAPAN (14.56 billion Japanese Yen [US$137.89 million] of which 90% was Pre-Clinical Business).

Sales Analysis. Syngene International Ltd reported sales of 20.12 billion Indian Rupees (US$268.99 million) for the fiscal year ending March of 2020. This represents an increase of 10.2% versus 2019, when the company's sales were 18.26 billion Indian Rupees . Sales at Syngene International Ltd have increased during each of the previous five years (and since 2015, sales have increased a total of 134%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Syngene International Ltd
  Stock Performance Chart for Syngene International Ltd
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 471.35
(Figures in Indian Rupees )
1 Week -3.3%   13 Weeks 7.1%  
4 Weeks 49.4%   52 Weeks 50.0%  
Syngene International Ltd Key Data:
  Ticker: SYNGENE Country: India
  Exchanges: NSE Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 20,119,000,000
(Year Ending Jan 2021).
Employees: 4,946
  Currency: Indian Rupees Market Cap: 186,907,514,626
  Fiscal Yr Ends: March Shares Outstanding: 396,536,575
  Share Type: Ordinary Closely Held Shares: 294,854,632
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.